Maximum quantity allowed is 999
CAS RN: 82640-04-8 | Product Number: R0109
Raloxifene Hydrochloride

Purity: >98.0%(T)(HPLC)
- [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride
Size | Unit Price | Hyderabad | Japan* | Quantity |
---|---|---|---|---|
1G |
₹13,200.00
|
2 | ≥40 |
|
5G |
₹29,900.00
|
3 | 29 |
|
*Upon orders receipt, Hyderabad stocks will be dispatched on the same day.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
Product Number | R0109 |
Purity / Analysis Method | >98.0%(T)(HPLC) |
Molecular Formula / Molecular Weight | C__2__8H__2__7NO__4S·HCl = 510.05 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
CAS RN | 82640-04-8 |
Related CAS RN | 84449-90-1 |
Reaxys Registry Number | 6036780 |
PubChem Substance ID | 172089090 |
Merck Index (14) | 8098 |
MDL Number | MFCD01938233 |
Appearance | Light yellow to Yellow to Green powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 98.0 % |
Melting Point | 263 °C |
Maximum Absorption Wavelength | 286 nm |
Pictogram |
![]() |
Signal Word | Warning |
Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
RTECS# | PC4956925 |
References
- Molecular determinants for the tissue specificity of SERMs
- The selective estrogen receptor modulator, raloxifene: An overview of nonclinical pharmacology and reproductive and developmental testing
- Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats
- Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6- hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity
- Molecular basis of agonism and antagonism in the estrogen receptor
- Tamoxifen, raloxifene, and the prevention of breast cancer
Articles/Brochures
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.